Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors

Earlier we had shown that the MDM2 inhibitor (MI-219) belonging to the spiro-oxindole family can synergistically enhance the efficacy of platinum chemotherapeutics leading to 50% tumor free survival in a genetically complex pancreatic ductal adenocarcinoma (PDAC) xenograft model. In this report, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Azmi, Asfar S., Banerjee, Sanjeev, Ali, Shadan, Wang, Zhiwei, Bao, Bin, Beck, Frances W.J., Maitah, Main, Choi, Minsig, Shields, Tony F., Philip, Philip A., Sarkar, Fazlul H., Mohammad, Ramzi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248191/
https://www.ncbi.nlm.nih.gov/pubmed/21623005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248191/
https://www.ncbi.nlm.nih.gov/pubmed/21623005

Ejemplares similares